M/DBP Stage 2 Federal Advisory Committee (FACA2)
Health Effects Data Update and Discussion of Problems/Solutions for Stage 2
Meeting Summary - January 2000
Meeting #8
January 12-13, 2000
Washington, DC
March 15, 2000
Table of Contents
I Introduction
II Discuss and Revise List of Problems/Solutions for Stage 2
II.1. FACA Plenary Discussion of Caucus Lists of Problems and Solutions
II.2. Interest Group Caucuses Identification of Problems/Solutions & Consolidation of These
Lists into the Consolidated List of Solutions/Questions for the TWG 3
III Overview of DBP Reproductive and Developmental Health Effects Data:
Epidemiology and Toxicology
III.1. Reproductive and Developmental Effects of Exposure to DBPs: An overview of
epidemiological data
III.2. Reproductive and Developmental Toxicity Assessment of Drinking Water Contaminants:
Stage 2 DBPs
IV Next Steps
V Public Comment
ATTACHMENTS
I.a Meeting Participants - M/DBP FACA, January 12-13, 2000
I.b Meeting Agenda - MDBP FACA, January 12-13, 2000
I.c TWG Guiding Principles - draft from January 10 TWG meeting notes
II.a draft Problems/Solutions List - December M/DBP FACA meeting
II.b draft Caucus Lists of Problems and Solutions
II.c draft Joint-Plenary Problem Statements List - January M/DBP FACA meeting
II.d draft Consolidated List of Solutions/Question for the TWG
III.a Reproductive and Developmental Effects of Exposure to DBPs: John S. Reif,
Department of Environmental Health - Colorado State University, January 13, 2000
III.b Reproductive and Developmental Toxicity Assessment of Drinking Water
Contaminants: Stage 2 DBPs: R.W.Tyl, Research Triangle Institute, January 13, 2000
Introduction
On January 12-13, 2000, EPA held the eighth meeting of the Stage 2 Disinfection Byproducts
and Long-Term 2 Enhanced Surface Water Treatment Rules (MDBP) Federal Advisory
Committee (FACA). The purpose of this meeting was to refine the problems/solutions
document developed in at the December FACA meeting and thereby provide direction to the
TWG. Health effects experts John Reif and Rochelle Tyl presented an update on
epidemiological and toxicological DBP data. This was an unprecedented meeting for the
FACA because there was no presentation from the TWG. See Attachment I.a for a list of
meeting participants and Attachment I.b for the draft meeting agenda.
Arnold reminded participants that a public comment period is included each meeting day for
non-FACA members to present or comment on data, or voice their views and opinions.
Arnold reported that the TWG held a two-day meeting earlier in the week on January 10-11.
Prior to the TWG meeting, FACA members and interested parties received the draft TWG
agenda and draft TWG groundrules. The TWG decided that instead of adopting the draft
groundrules they would clarify the informal guiding principles that TWG members have
developed over time, and which have been successful in the past. Notes from the discussion of
the TWG's guiding principals are included as Attachment I.c. All TWG work and products are
available to the FACA.(1) In response to the large workload and additional FACA meetings, the
TWG added a few meeting dates. The current TWG schedule is:
- January 25-26 - SWAT meeting, Denver, CO
- January 31-1 Feb. - Microbial occurrence, Washington, DC (RESOLVE)
- March 7-8 - (RESOLVE)
- April 17-18 - (RESOLVE)
- May 16-17 - (RESOLVE)
- June 26 - (RESOLVE)
The FACA adopted the proposed revisions to the FACA groundrules extending the schedule
for Stage 2 negotiations until July 31, 2000. This meeting report summarizes the presentations
and plenary discussions, and proposed next steps from this meeting.
II Discuss and Revise List of Problems/Solutions for Stage 2
FACA members reviewed the draft Problems/Solutions List from the December FACA
meeting [Attachment II.a.]
After a full discussion, the FACA agreed to meet in interest group caucuses to discuss and
bring back to the FACA Plenary group the problems and solutions that FACA members think
will best move the group forward. FACA members broke into four interest group caucuses
(utility, government, health/environment, and equipment manufactures) and began their
deliberations.
II.1. FACA Plenary Discussion of Caucus Lists of Problems and Solutions
Following the caucus discussions the FACA reconvened in Plenary to present and discuss the
flipchart notes produced in the caucuses. The transcribed notes from the utility, government,
and health/environment caucuses were distributed to meeting participants [Attachment II.b.]
The FACA plenary reviewed the notes from each caucus. A FACA member noted that the
amount of consistency between the caucuses is remarkable, others around the table agreed.
At the suggestion of a FACA member, the Plenary agreed that the way to proceed was to
continue in Plenary session and to consolidate the caucuses' problem statements into a single
Joint-Plenary Problems Statement list [Attachment II.c.] The FACA members agreed on four
groundrules for this discussion:
a. The joint-problem statements reflects a first cut or "straw" draft at identifying those
problems FACA members agree the FACA ought to address.
b. It does not preclude any discussion of additional problems, questions, or information
from occurring.
c. The list is not comprehensive or complete, in other words there are other problems
respective caucus members may want the FACA to address.
d. The list does not represent a consensus by the FACA.
The following points were made during the discussion of a Joint-Problems Statement:
FACA members expressed concern that there is great uncertainty surrounding mixtures
of DBP, or the DBP "soup." A FACA member noted that the FACA may not be
looking at the correct or most sensitive endpoints. Uncertainty regarding the correct
endpoints to focus on is a direct result of the uncertainty surrounding the DBP soups.
Toxicological data focuses on specific DBPs and specific endpoints. There are limited
epidemiological studies. A FACA member suggested that one approach would be to
looker more broadly by lumping cancer and reproductive and developmental effects to
identify overall risk.
Unknown/unidentified DBPs may be important in producing health effects. Surrogates
should be identified and utilized.
Elevated DBP exposure may be primarily the result of variability. Variable spatial and
temporal exposure may need to be addressed.
FACA members from the utilities caucus discussed their view that cancer data is not
compelling enough to warrant a major shift in technology. However, there is enough data
to justify efforts to tweak systems and technology to reduce variability.
A FACA member expressed concern that some members may feel that the lack of new
health effects data means that the FACA should not act and that the lack of new data
does indicate that there is no problem or no risk.
Cancer endpoints as well as all other potential health effect of DBPs need to be
addressed by the FACA. The data base on DBP cancer effects was robust when the
Stage 1 Rule was developed. There have not been many new cancer studies since then
(though a few have been published since the 80/60 Rule). However, there has been
incrementally growing data base on reproductive and development effects that are
cumulatively important.
Day one, January 12, of the FACA meeting adjourned following this discussion.
II.2. Interest Group Caucuses Identification of Problems/Solutions & Consolidation of
These Lists into the Consolidated List of Solutions/Questions for the TWG
On day two, January 13, FACA members agreed to meet by interest area caucuses and, using
the Joint Problem Statements as a guide, come up with a list of items or topics that they would
like the TWG to analyze. One use of these lists would be to provide the TWG with direction
for what data and analysis to prioritize in the coming months. Caucuses were asked to raise or
phrase questions so that they can be answered, e.g., "what would happen if...."
Technical consultants McGuire and Summers, along with McLain and Regli of EPA, used the
flipchart notes taken from the FACA caucuses to compile a draft Consolidated List of
Solutions/Questions for the TWG. The consultants worked quickly during the Reif and Tyl
DBP health effects data presentations. This technical team was asked to combine solutions and
questions identified by the respective caucuses whenever possible. When this list was presented
some of the respective caucus participants raised concerns that the draft did not adequately
reflect caucus discussions. FACA members agreed to review the list and return comments to
RESOLVE for inclusion in the list by January 21, at 12 noon EST. RESOLVE will send out a
revised list via e-mail by COB Jan. 21.(2) See attachment II.d for the revised Consolidated List.
The TWG will use the Consolidated List to prioritize their activities over the next few months.
However, questions on the List are not a reflection of the FACA priorities. The TWG will sort
out what it can answer quickly, and a schedule for all remaining questions.
FACA members made additions and modifications to the list during this discussion. These have
been incorporated into the Consolidated list. The following are points made by FACA
members during their discussion of the original draft Consolidated List:
- A FACA member began the discussion of the Consolidated List by acknowledging the
good work of the Technical Consultants and other staff who worked to consolidate the
information from the caucuses.
- The FACA needs information to identify the "knee of the curve", the point at which
technology shifts become necessary or large costs are incurred.
- There are different levels of understanding around the room regarding different regulatory
options. Some options, for instance, may be ineffective or too expensive, but they should
still be considered. Information on effectiveness and cost should be shared at the table
among FACA members.
III Overview of DBP Reproductive and Developmental Health Effects
Data: Epidemiology and Toxicology
John Reif, Colorado State University, and Rochelle Tyl, Research Triangle Institute, were
invited by the FACA to present overviews and updates of epidemiology and toxicology data on
DBP reproductive and developmental health effects. Reif and Tyl presented DBP health effects
data at the July FACA meeting.(3)
III.1. Reproductive and Developmental Effects of Exposure to DBPs: An overview of
epidemiological data
John Reif, Department of Environmental Health - Colorado State University, presented an
overview of epidemiological data [Attachment III.a] covering:
1) The results of recent epidemiological studies of reproductive and developmental
outcomes and DBPs and re-analysis of earlier studies provided by several investigators.
2) The preliminary summary of the Colorado State University's report to Health Canada
summarizing reproductive and developmental effects. The evidence for association with
adverse reproductive and developmental outcomes. And how epidemiological data can
be used to establish concentrations of THMs which may be health hazards.
3) Summary of strength and weaknesses of the epidemiological data base, relationship to
risk assessment.
This presentation is based on a presentation Reif made in November 1999 to Health Canada
regarding balancing risks of microbial and DBP exposure. Reif also cited the notes from his
presentation to the FACA in July 1999 as a source of additional information.
Reif concludes from epidemiology data on DBPs on female reproductive and developmental
health outcomes:
- Reproductive and developmental health endpoints are sensitive to environmental
toxicants.
- Small increases in risk are of public health significance due to ubiquity of exposure -
outcomes are common so even a small change could have a large public health impact.
- Short interval between exposure and disease manifestation (latency) -unlike the situation
in cancer, makes these endpoints much easier to study.
Reif reviewed the epidemiology data base for reproductive and developmental outcomes from
disinfected water in general and specifically for THMs, and broke out existing studies by what
endpoints were assessed, study type, and disinfection method studied.
Reif presented a summary of the studies that addressed the following outcomes and that
incorporated estimates of exposures to TTHMs. These outcomes include low birth weight,
small for gestational age, prematurity, congenital defects and spontaneous abortion/stillbirth. He
showed a series of slides which plotted the exposure levels for TTHMs used in each of the
studies for each outcome. He described in some detail two studies that were also discussed in
July. The California Prospective Cohort study of spontaneous abortion had a population of
about 5000 women who were followed through the course of their pregnancy. An association
with spontaneous abortion and consumption of 5 or more glasses of water daily containing 75
ppb TTHM or more was found and was strongest for exposure to bromodichloromethane.
This data has is being reanalyzed. The Nova Scotia Historical Cohort Study found a
statistically significant incidence of stillbirth at TTHM levels greater than 100 parts per billion,
but unlike most of the other studies, did not show associations with low birth weight, small for
gestational age or congenital defects.
In response to a questions from a FACA member, Reif explained that the studies that only
looked at crude indicators of DBPs such as water source or disinfection method are not very
useful in identifying dose/response relationship or causality. They may still be useful however,
since we do not know what the important component of the byproduct mixture actually is.
One goal is to identify surrogates which will assist in identifying exposure levels in these studies.
Reif presented a slide comparing the findings of four studies for stillbirths and spontaneous
abortions (SABs). SABs and stillbirths can be considered together from the standpoint that
they are part of the same continuum of effects. This is not a meta-analysis, but a comparison of
results of different studies. The graph indicates possible evidence of a dose-response
relationship. Comparing point estimates to the zero effect estimate line (1.0) shows a slight
increase with rising TTHM concentration. In response to a question regarding "threshold" for
effects Reif explained that misclassification of exposure and variability between individuals in the
middle of the range makes it very difficult to evaluate the potential existence of a threshold or to
accurately describe a dose-response relationship if one exists.
Finding for low birth weight include one study with no effect, one study with significant but low
effect, and two studies with significantly elevated effects. Reif also reviewed intrauterine growth
retardation, pre-term delivery, and data on neural tube defects. In response to a question Reif
noted that differences between study populations due to ethnicity have been accounted for in
the study design but the question of genetic differences between subjects has not been
addressed to date.
Reif reviewed the risk assessment paradigm: hazard identification, exposure assessment, dose-response relationship, and risk characterization. Using this analogy, the reproductive data can
contribute to the hazard identification and exposure assessment components, but are not yet
adequate to fully describe dose-response relationships or to permit risk characterization for
specific levels of DBPs. Reif believes that risk estimates tend to be low because of non-differential mis-classification of exposure data. There is not enough epidemiology data to
answer the Risk Characterization question: which components of the DBP mixture must be
reduced, and to what extent, to bring the risk to an "acceptable" level?
In the discussion following his presentation Reif and FACA members made the following points:
- Reif explained that in Stage 1 the FACA had to consider causality for cancer. With only
five studies there was not enough data to make statements regarding causality, the risk
was not very large, there was not adequate dose/response data, nor were there other
large databases to contribute to the weight of evidence. This data, however, still suggests
possibility of hazard.
- A FACA member noted that pharmaceuticals and other contaminants in source water
could be indicators of very different types of pollution. There may be relationships
between different types of water contaminants that are not currently understood.
- In response to a question Reif noted that social status has been considered in each of
these studies. There has been no convincing demonstration that DBPs are higher in
poorer communities. Studies have used indicators of socioeconomic status such as
maternal or paternal education, or other surrogates for family income to control for
social/economic status. He referred to the following table to show that these studies had
taken socioeconomic status into account in multivariate analysis and therefore it was not
likely to be an important source of confounding.
Reif: Studies included in presentation and risk factors included
Factor: |
Age |
Race |
Education |
Smoking |
Prenatal
care |
Study |
|
|
|
|
|
Kramer |
y |
|
y |
y |
y |
Bove |
y |
y |
y |
|
y |
Savitz |
y |
y |
y |
y |
|
Gallagher |
y |
white |
y |
y |
y |
Klutz |
y |
y |
y |
|
y |
Waller |
y |
y |
y |
y |
|
Dodds |
y |
|
family income |
y |
y |
- A FACA member noted the number of children born with neural tube defects is quite
large. Reif added that there is a body of toxicologic data that addresses this, and there
may be data that suggests a mechanistic relationship.
III.2. Reproductive and Developmental Toxicity Assessment of Drinking Water
Contaminants: Stage 2 DBPs
Rochelle Tyl, RTI, presented an overview of the reproductive and developmental toxicity data
base for Stage 2 DBPs [Attachment III.b.] Tyl also reviewed what will be covered in her
preliminary technical appraisal of the DBP toxicology database.
Tyl reviewed findings from the hazard characterization, and reviewed caveats regarding the
analysis. Most DBPs in the analysis have been assessed in in vitro and/or in vivo screening
studies. Many have "intrinsic capacity to do harm" to mammalian reproduction and/or
development, especially brominated DBPs. She added that present studies may include
inappropriate routes of exposure and only account for short-term exposure. Though male
reproductive toxicity has been studied, there is a lack of data for female reproductive toxicity.
Developmental toxicity has been the focus because a developing system is likely to be more
vulnerable to adverse effects than an adult. Tyl reviewed the new ongoing initiatives to collect
dose response data and a schedule for results from various studies on BDCM and DBA. EPA
also has a collaborative research project with Colorado State University and EPA in-house
studies.
RTI's review of the DBP toxicology data base will cover 33 DBPs, a table of endpoints, table
of studies, weight-of-evidence, and information needed to fill data gaps. Weight-of-evidence is
determined by combining the findings of smaller studies.
In response to question a question on thresholds for effects, Tyl explained that, in her
experience, data suggests that there is a threshold for effects from DBPs. There is an
assumption that developmental and reproductive effects, if they exist, manifest as a non-linear
dose-response. The capacity to determine a threshold effect depends in part on which
endpoints are being evaluated. For example, focusing on the effects to cells may miss damage
on the molecular or DNA level since the cell may be able to repair. Large study populations in
determining effects and threshold levels are important because of intra-species variation.
Existing studies test for exposures much greater (by a factor of 100 to 10,000) than actual
human exposures.
Studies look at more than one species because we do not know the relevance of effects across
species. If an effect is seen in two different species (e.g. rats and rabbits) we assume that the
toxin will effect humans. The default is to use the most sensitive effect. If we know the
mechanism of the effect, then we can use that information to understand if the effect will be seen
in other species.
IV Next Steps
FACA members discussed the following next steps:
1. Review the draft Consolidated List and returned additions and comments to RESOLVE for
inclusion in a revised draft. The revised draft will be circulated to FACA members for
review, then circulated to all interested parties.
2. Anticipated February FACA Agenda Items
- TWG Report: (1) Baseline, (2) If possible, answers to some of the questions on the
Consolidated List (3) Schedule for answers to the balance of questions on Consolidated
List
- Caucus Time
V Public Comment
No speakers asked to address the FACA.
Adjourn
Footnotes
1. Contact Eddie Scher, RESOLVE, if you would like more information on any TWG activities or would like to
join the TWG e-mail list-serve.
2. Submissions were incorporated and the revised List was distributed by e-mail to FACA members for
review on January 21, 2000. After this review the Consolidated List will be distributed to all M/DBP FACA
interested parties.
3. Presentation materials and meeting summary from the July FACA meeting are available by contacting
Eddie Scher, RESOLVE, at escher@resolv.org or by phone at 202-965-6203.
|